Last reviewed · How we verify
NCT05463042
Intermittent Hypoxia and Balance Control
NA trial testing Intermittent Hypoxia in Intermittent Hypoxia in 3 participants. Completed in 21 August 2023.
21 August 2023
Quick facts
| Lead sponsor | University of Texas at Austin |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 3 |
| Start date | 1 September 2022 |
| Primary completion | 21 August 2023 |
| Estimated completion | 21 August 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Intermittent Hypoxia
- Normoxia (sham)
Conditions studied
- Intermittent Hypoxia — all drugs for Intermittent Hypoxia →
- Normoxia — all drugs for Normoxia →
Sponsor
University of Texas at Austin
Who can join
Adults 18 to 80, any sex, with Intermittent Hypoxia or Normoxia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to determine the effect of acute mild intermittent hypoxia on ankle plantarflexor muscle output during balance regulation and walking in younger and older adults. Fifteen younger adults and 15 older adults will be recruited to participate in the cross-over design study that requires 2 visits (at least 1-week apart). Participants will be pseudo-randomly assigned to receive either intermittent hypoxia or sham during the first visit, and then switch over to receive sham or intermittent hypoxia during the 2nd visit. Muscle activation patterns and kinetic and kinematics during standing and walking will be recorded before and after the intermittent hypoxia/sham. It is hypothesized that compared to the sham condition, both younger and older participants will show greater increases in ankle plantarflexor muscle activation during gait and balance assessments following intermittent hypoxia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05463042
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intermittent Hypoxia
Trials testing the same drug.
- NCT07394699 — Efficiency of Intermittent Hypoxia Intervention in Primary Insomnia · NA · not yet recruiting
- NCT05824104 — Exploratory Study of Intermittent Hypoxia Treatment in Chronic Cerebral Hypoperfusion · NA · unknown
- NCT05733338 — The Effects of Intermittent Hypoxia on Acute Hypoxic Injury · NA · unknown
- NCT04280484 — Acute Intermittent Hypoxia in Persons With Multiple Sclerosis · NA · completed
- NCT03029559 — Intermittent Hypoxia and Inspiratory Threshold Loading to Enhance Inspiratory Muscle Function · NA · completed
Other University of Texas at Austin trials
Trials by the same sponsor.
- NCT07319234 — Development of MENU Protocol · NA · not yet recruiting
- NCT07480109 — Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) · NA · not yet recruiting
- NCT07069413 — Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children · NA · not yet recruiting
- NCT07370311 — A Culturally Adapted Decision Aid Intervention to Support Chinese American Dementia Caregivers in Feeding-Related Decisi · NA · not yet recruiting
- NCT07441122 — Enhancing Attention in Elderly Using a Brain-Computer-Interface · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05463042 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Texas at Austin
- Last refreshed: 29 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05463042.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing